These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 6877484)

  • 1. Amelioration of age-related neurochemical and behavioral deficits by 3,4-diaminopyridine.
    Peterson C; Gibson GE
    Neurobiol Aging; 1983; 4(1):25-30. PubMed ID: 6877484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 3,4-diaminopyridine alters acetylcholine metabolism and behavior during hypoxia.
    Peterson C; Gibson GE
    J Pharmacol Exp Ther; 1982 Sep; 222(3):576-82. PubMed ID: 6286925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synaptosomal calcium metabolism during hypoxia and 3,4-diaminopyridine treatment.
    Peterson C; Gibson GE
    J Neurochem; 1984 Jan; 42(1):248-53. PubMed ID: 6689690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential alteration of dopamine, acetylcholine, and glutamate release during anoxia and/or 3,4-diaminopyridine treatment.
    Freeman GB; Mykytyn V; Gibson GE
    Neurochem Res; 1987 Nov; 12(11):1019-27. PubMed ID: 2891059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subsynaptosomal distribution of calcium during aging and 3,4-diaminopyridine treatment.
    Peterson C; Nicholls DG; Gibson GE
    Neurobiol Aging; 1985; 6(4):297-304. PubMed ID: 4088426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of 3,4-diaminopyridine on acetylcholine release at the frog neuromuscular junction.
    Durant NN; Marshall IG
    Eur J Pharmacol; 1980 Oct; 67(2-3):201-8. PubMed ID: 6970132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aging and 3,4-diaminopyridine alter synaptosomal calcium uptake.
    Peterson C; Gibson GE
    J Biol Chem; 1983 Oct; 258(19):11482-6. PubMed ID: 6619125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Release of acetylcholine from tissue slices of the rat nucleus basalis magnocellularis.
    Metcalf RH; Boegman RJ
    J Neurochem; 1989 Apr; 52(4):1143-8. PubMed ID: 2522538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in cytosolic free calcium with 1,2,3,4-tetrahydro-5-aminoacridine, 4-aminopyridine and 3,4-diaminopyridine.
    Gibson GE; Manger T
    Biochem Pharmacol; 1988 Nov; 37(21):4191-6. PubMed ID: 2847755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ineffectiveness of 3,4-diaminopyridine as a therapy for type C botulism.
    Siegel LS; Price JI
    Toxicon; 1987; 25(9):1015-8. PubMed ID: 3433299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholinergic nerve terminals in the ventrolateral medullary pressor area: pharmacological evidence.
    Sundaram K; Sapru H
    J Auton Nerv Syst; 1988 Apr; 22(3):221-8. PubMed ID: 3418015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improvement of 8-arm maze performance in aged Fischer 344 rats with 3,4-diaminopyridine.
    Davis HP; Idowu A; Gibson GE
    Exp Aging Res; 1983; 9(3):211-4. PubMed ID: 6641784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of tacrine, velnacrine (HP029), suronacrine (HP128), and 3,4-diaminopyridine on skeletal neuromuscular transmission in vitro.
    Braga MF; Harvey AL; Rowan EG
    Br J Pharmacol; 1991 Apr; 102(4):909-15. PubMed ID: 1649660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of charybdotoxin, a blocker of Ca2+-activated K+ channels, on motor nerve terminals.
    Anderson AJ; Harvey AL; Rowan EG; Strong PN
    Br J Pharmacol; 1988 Dec; 95(4):1329-35. PubMed ID: 2464391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of 3,4-diaminopyridine and tetraethylammonium on the presynaptic blockade caused by beta-bungarotoxin.
    Chang CC; Su MJ
    Toxicon; 1980; 18(4):481-4. PubMed ID: 6259776
    [No Abstract]   [Full Text] [Related]  

  • 16. The effect of some new aminopyridines on mammalian non-myelinated nerve fibres.
    Den Hertog A; Pielkenrood J; Biessels P; Agoston S
    Eur J Pharmacol; 1983 Oct; 94(3-4):353-5. PubMed ID: 6653665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3,4-Diaminopyridine and choline increase in vivo acetylcholine release in rat striatum.
    Buyukuysal RL; Ulus IH; Aydin S; Kiran BK
    Eur J Pharmacol; 1995 Aug; 281(2):179-85. PubMed ID: 7589205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholinergic drugs and 4-aminopyridine alter hypoxic-induced behavioral deficits.
    Gibson GE; Pelmas CJ; Peterson C
    Pharmacol Biochem Behav; 1983 Jun; 18(6):909-16. PubMed ID: 6136988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antagonism of non-depolarising neuromuscular blockade by aminopyridines in cats.
    Riesz M; Kápáti E; Szporny L
    J Pharm Pharmacol; 1986 Feb; 38(2):156-8. PubMed ID: 2870165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of some pharmacological properties of 4-aminopyridine and 3,4-diaminopyridine in vivo.
    Houston T; Pleuvry BJ
    Br J Anaesth; 1984 Oct; 56(10):1139-42. PubMed ID: 6148094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.